-- Entered into a two-year research project to be carried out at Thomas
Jefferson University in Philadelphia and Laboraf Diagnostica e
Ricerca San Raffaele SpA in Milan. This research will seek to
discover genetic signatures for cardiovascular disease and obesity-
related hypertension, which would yield exclusive proprietary
content for Beckman Coulter's molecular diagnostics system.
-- Elected Susan R. Nowakowski, chief executive officer, president, and
director of AMN Healthcare Services, Inc., to the company's Board of
-- Named Scott Garrett, the company's current President and Chief
Executive Officer, as Chairman of the Board, President and Chief
Executive Officer, effective April 24, 2008.
-- Named Betty Woods, the company's current non-executive Chairman, as
Lead Independent Director, effective April 24, 2008.
-- Declared a $0.17 per share quarterly cash dividend, a $0.01 per
share, or 6.3% increase, payable on March 7, 2008 to all
stockholders of record on February 22, 2008. This payout represents
the 75th consecutive quarterly dividend.
-- Announced that the company's Board of Directors authorized the
repurchase of up to 2.5 million shares of the company's outstanding
-- Entered into agreements with the National University of Ireland,
Galway, to direct assay research and acquire licenses for
intellectual property as part of the development of infectious
disease tests for Beckman Coulter's molecular diagnostics
Full Year 2007 Discussion
Revenue for full year 2007 was $2,761.3 million, up 9.2% over prior
year, or 6.8% in constant currency. The 2006 acquisition of Lumigen
|SOURCE Beckman Coulter, Inc.|
Copyright©2008 PR Newswire.
All rights reserved